Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 2/20 | 0.69 |
| ▸ | LPAR5 | Q9H1C0 | 4/20 | 0.59 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.46 |
| ▸ | LPAR2 | Q9HBW0 | 4/20 | 0.46 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.46 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.46 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1965457 | 1.00 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CMEN1 | |
| SCHEMBL4287322 | 1.00 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CMEN1 | |
| SCHEMBL9248716 | 1.00 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CMEN1 | |
| SCHEMBL8022797 | 1.00 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CMEN1 | |
| SCHEMBL116830 | 1.00 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CMEN1 | |
| SCHEMBL8856104 | 1.00 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CMEN1 | |
| SCHEMBL24835077 | 1.00 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CMEN1 | |
| SCHEMBL932977 | 1.00 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CMEN1 | |
| SCHEMBL1086330 | 1.00 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CMEN1 | |
| SCHEMBL21082980 | 1.00 | USP2 (1.00) | USP2HTTLPAR5PLA2G2CMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6135 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026107335-A1 | COMPOSITIONS AND METHODS FOR TREATING HEPATIC DISEASES BY INHIBITING EFHD1 | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2026-05-21 | — | — | WO | claimed |
| WO-2026090085-A1 | TREATMENT OF CD33 RELATED DISEASES AND DISORDERS | EMPIRICO INC. (US) | 2026-04-30 | — | — | WO | claimed |
| US-12565653-B2 | ATAXIN3 (ATXN3) RNAi agent compositions and methods of use thereof | ALNYLAM PHARMACEUTICALS, INC. (US) | 2026-03-03 | — | — | US | claimed |
| US-12553053-B2 | Transmembrane serine protease 2 (TMPRSS2) iRNA compositions and methods of use thereof | ALNYLAM PHARMACEUTICALS, INC. (US) | 2026-02-17 | — | — | US | claimed |
| US-20260041650-A1 | COMPOSITION FOR LIVING BODY | FUJIFILM CORPORATION (JP) | 2026-02-12 | — | — | US | claimed |
| US-12534731-B2 | Alpha-2A adrenergic receptor (ADRA2A) iRNA agent compositions and methods of use thereof | ALNYLAM PHARMACEUTICALS, INC. (US) | 2026-01-27 | — | — | US | claimed |
| EP-4661856-A1 | PLASMALOGEN MODULATION OF IMMUNE CELLS | Baker Heart and Diabetes Institute (AU) | 2025-12-17 | — | — | EP | claimed |
| US-20250353872-A1 | Ligand-Modified Oligonucleotides | NOVO NORDISK A/S (DK) | 2025-11-20 | — | — | US | claimed |
| US-20250333730-A1 | SIRNA FOR INHIBITING ANGPTL3 GENE EXPRESSION AND USE THEREOF | SHANGHAI JUNSHI BIOSCIENCES CO LTD (CN) | 2025-10-30 | — | — | US | claimed |
| EP-4627082-A1 | TREATMENT OF MTRES1 RELATED DISEASES AND DISORDERS | EMPIRICO INC. (US) | 2025-10-08 | — | — | EP | claimed |
| CN-1494924-A | Bone substitute material utilizing bio-absorbable liquid polymer | 伊西康公司 | 2004-05-12 | — | — | CN | claimed |
| CN-1471907-A | Particle for releasing polymer coating | — | 2004-02-04 | — | — | CN | claimed |
| US-5827920-A | STABLE SURFACTANT-FREE AQUEOUS MIXTURES OF ACRYLIC ACID-METHACRYLIC ACID COPOLYMERS, SOLID HIGHER ALCOHOLS, SILICONE OILS, FOR COSMETICS HAVING GOOD ORGANOLEPTIC PROPERTIES | SHISEIDO COMPANY, LTD. (JP) | 1998-10-27 | — | — | US | claimed |
| JP-2690620-B2 | — | — | 1997-12-10 | — | — | JP | claimed |
| US-5679355-A | ENTRAPPED ANTIGENS ACT AS POTENT IMMUNOLOGICAL ADJUVANTS; GLYCEROL ESTERS | PROTEUS MOLECULAR DESIGN LIMITED (GB) | 1997-10-21 | — | — | US | claimed |
| EP-0634937-B1 | VACCINES CONTAINING NON-IONIC SURFACTANT VESICLES | PROTEUS MOLECULAR DESIGN (GB) | 1997-09-17 | — | — | EP | claimed |
| EP-0634937-A1 | VACCINES CONTAINING NON-IONIC SURFACTANT VESICLES. | PROTEUS MOLECULAR DESIGN (GB) | 1995-01-25 | — | — | EP | claimed |
| CN-1085449-A | Vaccine or relative improvement | PROTEUS MOLECULAR DESIGN (GB) | 1994-04-20 | — | — | CN | claimed |
| WO-1993019781-A1 | VACCINES CONTAINING NON-IONIC SURFACTANT VESICLES | PROTEUS MOLECULAR DESIGN LIMITED (GB) | 1993-10-14 | — | — | WO | claimed |
| US-4737360-A | POLLEN EXTRACT AND VEGETABLE OILS | CERNITIN AMERICA, INC. (US) | 1988-04-12 | — | — | US | claimed |